p130Cas, Crk‐Associated Substrate, Plays Important Roles in Osteoclastic Bone Resorption
暂无分享,去创建一个
S. Kato | K. Aoki | K. Ohya | E. Jimi | M. Kurokawa | Y. Seta | K. Maki | H. Hikiji | Mariko Takahashi | S. Seo | H. Yasuda | H. Fukushima | Y. Tamura | H. Honda | I. Nakamura | K. Osawa | Yoshie Nagai
[1] R. Mecham,et al. Paxillin contracts the osteoclast cytoskeleton , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] H. Takayanagi,et al. New insights into osteoclastogenic signaling mechanisms , 2012, Trends in Endocrinology & Metabolism.
[3] David A. Williams,et al. Rac deletion in osteoclasts causes severe osteopetrosis , 2011, Journal of Cell Science.
[4] V. Vives,et al. The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts , 2011, Journal of Bone and Mineral Research.
[5] G. Karsenty,et al. Regulation of bone mass by serotonin: molecular biology and therapeutic implications. , 2011, Annual review of medicine.
[6] H. Kikutani,et al. Integral roles of a guanine nucleotide exchange factor, FARP2, in osteoclast podosome rearrangements. , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] S. Kato,et al. The Blimp1–Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis , 2010, The Journal of experimental medicine.
[8] T. Kodama,et al. Blimp1-mediated repression of negative regulators is required for osteoclast differentiation , 2010, Proceedings of the National Academy of Sciences.
[9] K. Aoki,et al. The pivotal role of the alternative NF‐κB pathway in maintenance of basal bone homeostasis and osteoclastogenesis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] K. Aoki,et al. Processing of the NF‐κB2 precursor p100 to p52 is critical for RANKL‐induced osteoclast differentiation , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] H. Takayanagi,et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis , 2009, Nature Medicine.
[12] B. Mayer,et al. Phosphorylation of p130Cas initiates Rac activation and membrane ruffling , 2008, BMC Cell Biology.
[13] Anne J. Ridley,et al. Mammalian Rho GTPases: new insights into their functions from in vivo studies , 2008, Nature Reviews Molecular Cell Biology.
[14] C. Marshall,et al. uPAR promotes formation of the p130Cas–Crk complex to activate Rac through DOCK180 , 2008, The Journal of cell biology.
[15] P. Chambon,et al. Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts , 2007, Cell.
[16] Soo Young Lee,et al. MafB negatively regulates RANKL-mediated osteoclast differentiation. , 2007, Blood.
[17] L. Addadi,et al. Involvement of the Src-cortactin pathway in podosome formation and turnover during polarization of cultured osteoclasts , 2006, Journal of Cell Science.
[18] Michael P. Sheetz,et al. Force Sensing by Mechanical Extension of the Src Family Kinase Substrate p130Cas , 2006, Cell.
[19] M. Hendrix,et al. Lysyl oxidase regulates actin filament formation through the p130Cas/Crk/DOCK180 signaling complex , 2006, Journal of cellular biochemistry.
[20] Paola Defilippi,et al. p130Cas: a versatile scaffold in signaling networks. , 2006, Trends in cell biology.
[21] S. Ogawa,et al. Crk-Associated Substrate Lymphocyte Type Is Required for Lymphocyte Trafficking and Marginal Zone B Cell Maintenance1 , 2005, The Journal of Immunology.
[22] W. Swat,et al. Vav3 regulates osteoclast function and bone mass , 2005, Nature Medicine.
[23] C. Der,et al. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors , 2005, Nature Reviews Molecular Cell Biology.
[24] T. Kitamura,et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. , 2003, Experimental hematology.
[25] Silvia Bernardini,et al. Decreased C-Src Expression Enhances Osteoblast Differentiation and Bone Formation , 2000, The Journal of cell biology.
[26] R. Hynes,et al. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. , 2000, The Journal of clinical investigation.
[27] R. Klemke,et al. Regulation of Cell Contraction and Membrane Ruffling by Distinct Signals in Migratory Cells , 1999, The Journal of cell biology.
[28] Michael P. Sheetz,et al. Selective regulation of integrin–cytoskeleton interactions by the tyrosine kinase Src , 1999, Nature Cell Biology.
[29] R. Insall,et al. Signaling to Actin Dynamics , 1999, The Journal of cell biology.
[30] J. Parsons,et al. Stable Association of PYK2 and p130Cas in Osteoclasts and Their Co-localization in the Sealing Zone* , 1999, The Journal of Biological Chemistry.
[31] G. Rodan,et al. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. , 1998, The Journal of clinical investigation.
[32] Kenji Nakamura,et al. Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas , 1998, Nature Genetics.
[33] G. Rodan,et al. Tyrosine Phosphorylation of p130Cas Is Involved in Actin Organization in Osteoclasts* , 1998, The Journal of Biological Chemistry.
[34] T. Pollard,et al. Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments. , 1998, Molecular biology of the cell.
[35] E. Jimi,et al. Regulation of Osteoclast Function , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] E. Jimi,et al. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] N. Takahashi,et al. Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts. , 1996, Endocrinology.
[38] K. Ozawa,et al. Direct Binding of C-terminal Region of p130 to SH2 and SH3 Domains of Src Kinase (*) , 1996, The Journal of Biological Chemistry.
[39] N. Udagawa,et al. A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders. , 1995, Bone.
[40] H. Varmus,et al. c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism. , 1995, Genes & development.
[41] Sakae Tanaka,et al. Wortmannin, a specific inhibitor of phosphatidylinositol‐3 kinase, blocks osteoclastic bone resorption , 1995, FEBS letters.
[42] S. Ogawa,et al. A novel signaling molecule, p130, forms stable complexes in vivo with v‐Crk and v‐Src in a tyrosine phosphorylation‐dependent manner. , 1994, The EMBO journal.
[43] M. Horton,et al. Biochemical characterization of human osteoclast integrins. Osteoclasts express alpha v beta 3, alpha 2 beta 1, and alpha v beta 1 integrins. , 1993, The Journal of biological chemistry.
[44] T. Yoneda,et al. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. , 1992, The Journal of clinical investigation.
[45] K. Väänänen,et al. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[46] Allan Bradley,et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.
[47] 丸山 俊正. Processing of the NF-κB2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation , 2011 .
[48] P. Chambon,et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. , 2007, Cell.
[49] M. Horton,et al. Biochemical Characterization of Human Osteoclast Integrins , 2001 .
[50] T. Pollard,et al. Actin dynamics. , 2001, Journal of cell science.